Elizabeth Cormier-May

Elizabeth Cormier-May has a diverse work experience in the healthcare and diagnostics industry. Elizabeth currently serves as the President & CEO and Chairman of the Board of Directors at Dragonfly Data Ventures, where they focus on empowering individuals to take control of their own data. In 2021, they also became the CEO of Mammogen, Inc., leading efforts to detect and diagnose diseases related to breast health. At IV BioHoldings, Cormier-May holds the role of Partner & Chief Commercial Officer, working towards improving disease detection and treatment on a global scale. Additionally, they serve as a Board Director at Safe & Green Holdings Corp., an Advisory Board Member at 2San and PragmaDx, Inc., and as the Healthcare Innovation and Diagnostics Advisor at Boat School Ventures. Before these roles, Cormier-May held prominent positions in other companies such as Exosome Diagnostics, Definiens, and HTG Molecular Diagnostics, where they made significant contributions in the field of commercial diagnostics and business development.

Elizabeth Cormier-May earned a Bachelor of Science degree with ACS Certification in Organic Chemistry from Wheaton College Massachusetts. Elizabeth attended the college from 2000 to 2004. Additionally, they pursued studies in Chemistry and Chemical Biology at Northeastern University, although specific details such as the start and end year or degree obtained are not provided.